ConductScience.org, home

Paper328137

Clinical trials in cancer chemotherapy.

Carter SK. Cancer, 1977. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Clinical trials in cancer chemotherapy. Papers, record 328137. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/328137

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical trials in cancer chemotherapy.
PubMed
Journal
Cancer
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article, Review
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.93
iCite
Revised in PubMed
2019-06-19
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carter SKS K

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Drug EvaluationMajor topic
NeoplasmsMajor topic
Animals
Clinical Trials as Topic
Drug Evaluation, Preclinical
Drug Therapy, Combination
Female
Human Experimentation
Humans
Male
Neoplasms, Experimental
Species Specificity

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
31477881Phase I trials as valid therapeutic options for patients with cancer.Nat Rev Clin Oncol2019https://conductscience.org/library/papers/31477881PubMed
7805184Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7805184PubMed
1644658Basic design considerations for clinical trials in oncology.Jpn J Cancer Res1992https://conductscience.org/library/papers/1644658PubMed
750106The clinical evaluation of analogues. I. The overall problem.Cancer Chemother Pharmacol1978https://conductscience.org/library/papers/750106PubMed
393427m-AMSA and PALA: two new agents in cancer chemotherapy.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/393427PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/328137

GET https://conductscience.org/api/papers/v1/328137/authors